Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group. [electronic resource] by
- Kern, W
- Behre, G
- Rudolf, T
- Kerkhoff, A
- Grote-Metke, A
- Eimermacher, H
- Kubica, U
- Wörmann, B
- Büchner, T
- Hiddemann, W
Producer: 19980731
In:
Cancer vol. 83
Availability: No items available.
|
|
|
19.
|
|
|
|
20.
|
Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative Group. [electronic resource] by
- Kern, W
- Aul, C
- Maschmeyer, G
- Kuse, R
- Kerkhoff, A
- Grote-Metke, A
- Eimermacher, H
- Kubica, U
- Wörmann, B
- Büchner, T
- Hiddemann, W
Producer: 19981112
In:
Annals of hematology vol. 77
Availability: No items available.
|